Dr. Jaya Sharma, MD

Dr. Sharma practices at Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System.

Dr. Sharma's NPI, 1710184197, was assigned on June 29, 2007. Dr. Sharma holds Illinois license 036.138655.

Dr. Sharma's primary practice is Mount Sinai Hospital, at 15th Street at California, Chicago, IL 60608 in Cook County. The practice phone is (773) 542-2000. Dr. Sharma also practices at Mount Sinai Hospital Medical Center, 1500 S Fairfield Ave, Chicago, IL 60608.

Dr. Sharma's primary practice is Mount Sinai Hospital in Chicago, Illinois, part of Sinai Health System. Dr. Sharma is also affiliated with Holy Cross Hospital. The medical group on file is Sinai Medical Group. Dmand AI also links Dr. Sharma to 1 more breast imaging center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharma practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sharma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Sharma's licenses on file in 3 states: Illinois, Massachusetts and Wisconsin.

CMS data shows 131 Medicare services from Dr. Sharma across 4 procedure codes in 2024, for 69 Medicare patients. Medicare paid $9,987 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Sharma in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 74% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharma's median patient age at 69, with 66% women.

In 2024, Dr. Sharma wrote 180 Medicare Part D claims for 48 patients. 97% of them were for generic drugs. CMS names the drug for 133 of them, across 5 drugs with 11 or more claims each, at $1,941 in total drug cost. In 2023, CMS named 162 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Sharma for performance year 2024, reported as part of a group. Dr. Sharma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Sharma, published from 2012 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Prions, Calcium and Fungal Proteins. Dr. Sharma's most frequent co-authors are Michael Anis, MD and Joanna Oluwatomisin Obaoye, MD.

CMS Open Payments shows 342 general payments to Dr. Sharma from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,207.